NDSN · Nordson Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · NDSN

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	-	$2.79B	$2.69B	$2.63B	$2.59B	$2.36B
Cost of Revenue	-	$1.25B	$1.20B	$1.20B	$1.16B	$1.04B
Gross Profit	-	$1.54B	$1.49B	$1.43B	$1.43B	$1.32B
R&D	-	$68.24M	$64.99M	$71.40M	$63.03M	$59.42M
SG&A	-	$815.51M	$812.13M	$752.64M	$724.18M	$708.95M
Total Operating Expenses	-	$2.08B	$2.02B	$1.96B	$1.89B	$1.75B
D&A	-	$79.26M	$136.18M	$103.88M	$49.10M	$53.33M
Operating Income	-	$711.73M	$674.00M	$672.76M	$702.36M	$615.13M
Interest Expense	-	$104.16M	$88.92M	$59.51M	$22.41M	$25.49M
Income Tax	-	$113.17M	$118.20M	$127.85M	$136.18M	$119.81M
Net Income	-	$484.47M	$467.28M	$487.49M	$513.10M	$454.37M
EPS - Basic	-	$8.56	$8.17	$8.54	$8.90	$7.82
EPS - Diluted	-	$8.51	$8.11	$8.46	$8.81	$7.74

Balance Sheet

Line item	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Cash & Equivalents	$120.39M◇	$108.44M	$115.95M	$115.68M	$163.46M	$299.97M
Accounts Receivable	-	$587.84M	$594.66M	$590.89M	$537.31M	$489.39M
Inventory	-	$444.81M	$476.94M	$454.77M	$383.40M	$327.19M
Accounts Payable	-	$121.01M	$97.84M	$106.32M	$99.28M	$91.69M
Current Assets	$1.25B◇	$1.24B	$1.28B	$1.23B	$1.13B	$1.16B
Total Assets	$5.96B◇	$5.92B	$6.00B	$5.25B	$3.82B	$3.79B
Current Liabilities	$460.05M◇	$758.26M	$528.48M	$582.09M	$834.20M	$445.39M
Long-term Debt	$1.94B◇	$1.68B	$2.10B	$1.62B	$345.32M	$781.71M
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	$3.11B◇	$3.04B	$2.93B	$2.60B	$2.29B	$2.16B
Retained Earnings	-	$4.60B	$4.30B	$3.99B	$3.65B	$3.27B

Cash Flow

Line item	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Operating Cash Flow	-	$719.17M	$556.19M	$641.28M	$513.13M	$545.93M
Investing Cash Flow	-	($26.69M)	($844.40M)	($1.44B)	($222.76M)	($33.17M)
Financing Cash Flow	-	($706.43M)	$294.50M	$750.51M	($416.01M)	($422.91M)
CapEx	-	$58.06M	$64.41M	$34.58M	$51.43M	$38.30M
Free Cash Flow	-	$661.12M	$491.78M	$606.70M	$461.70M	$507.62M

Ratios

Metric	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Profitability
Gross margin	-	55.2%	55.2%	54.2%	55.1%	56.1%
Operating margin	-	25.5%	25.1%	25.6%	27.1%	26.0%
EBITDA margin	-	28.3%	30.1%	29.5%	29.0%	28.3%
Net margin	-	17.4%	17.4%	18.5%	19.8%	19.2%
Free cash flow margin	-	23.7%	18.3%	23.1%	17.8%	21.5%
FCF / Net income	-	1.36	1.05	1.24	0.90	1.12
R&D / Revenue	-	2.4%	2.4%	2.7%	2.4%	2.5%
SG&A / Revenue	-	29.2%	30.2%	28.6%	28.0%	30.0%
Effective tax rate	-	18.9%	20.2%	20.8%	21.0%	20.9%
Return on assets	-	8.2%	7.8%	9.3%	13.4%	12.0%
Return on equity	-	15.9%	15.9%	18.8%	22.4%	21.0%
Return on invested capital	-	12.2%	10.7%	12.6%	21.0%	16.6%
Liquidity
Current ratio	2.72	1.64	2.41	2.11	1.36	2.62
Quick ratio	2.72	1.05	1.51	1.33	0.90	1.88
Cash ratio	0.26	0.14	0.22	0.20	0.20	0.67
Leverage
Debt / Equity	0.62	0.55	0.72	0.62	0.15	0.36
Debt / Assets	0.33	0.28	0.35	0.31	0.09	0.21
Debt / EBITDA	-	2.13	2.59	2.09	0.46	1.17
Interest coverage	-	6.8x	7.6x	11.3x	31.3x	24.1x
Equity multiplier	1.92	1.94	2.05	2.02	1.67	1.76
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	-	0.47	0.45	0.50	0.68	0.62
Inventory turnover	-	2.81	2.52	2.65	3.04	3.17
Days sales outstanding	-	77d	81d	82d	76d	76d
Days inventory outstanding	-	130d	145d	138d	120d	115d
Days payable outstanding	-	35d	30d	32d	31d	32d
Cash conversion cycle	-	171d	196d	188d	165d	158d
Valuation
P / E	-	27.3x	30.6x	25.1x	25.5x	32.8x
P / B	-	4.3x	4.9x	4.7x	5.7x	6.9x
P / S	-	4.7x	5.3x	4.7x	5.1x	6.3x
EV / EBITDA	-	18.7x	20.1x	17.7x	17.7x	23.1x
Growth
Revenue growth (YoY)	-	3.8%	2.3%	1.5%	9.7%	11.4%
Revenue CAGR (3y)	-	2.5%	4.4%	7.4%	7.8%	9.3%
Revenue CAGR (5y)	-	5.6%	5.4%	7.8%	7.4%	6.8%
Gross profit growth (YoY)	-	3.6%	4.3%	-0.1%	7.7%	17.1%
Operating income growth (YoY)	-	5.6%	0.2%	-4.2%	14.2%	76.0%
Net income growth (YoY)	-	3.7%	-4.1%	-5.0%	12.9%	82.1%
EPS growth (YoY)	-	4.9%	-4.1%	-4.0%	13.8%	81.3%
EPS CAGR (3y)	-	-1.1%	1.6%	25.6%	15.0%	6.5%
EPS CAGR (5y)	-	14.8%	7.0%	5.7%	11.6%	10.4%
FCF growth (YoY)	-	34.4%	-18.9%	31.4%	-9.0%	12.3%
FCF CAGR (5y)	-	7.9%	9.1%	19.9%	12.2%	17.4%
Book value growth (YoY)	2.3%	3.8%	12.9%	13.2%	6.3%	22.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-10-31.

Business segments

$2.79B total

Industrial Precisions Solutions$1.33B · 47.7%

Medical Fluid Systems$835.38M · 29.9%

Advanced Technology Systems$624.51M · 22.4%

Geographic

$3.71B total

Americas$1.21B · 32.5%

US$922.73M · 24.8%

Asia Pacific Excluding Japan$863.64M · 23.3%

Europe$722.22M · 19.4%

Stability scores

Piotroski F-score

FY 2026 · 9-point quality

1/9

Weak

-Net income positive
-Operating cash flow positive
-ROA improved YoY
-Cash flow > net income
✗Long-term debt decreased
✓Current ratio improved
-No share dilution
-Gross margin improved
-Asset turnover improved

Peer comparison

Same SIC group: General Industrial Machinery & Equipment, NEC

Company	Revenue (last FY)	Net margin	ROE
RRX	-	-	4.1%
ESAB	$2.84B	8.0%	10.5%
SYM	$2.25B	-0.8%	-7.7%
OUST	$169.38M	-35.6%	-23.1%
VLDR	$61.92M	-342.7%	-70.9%

Comparing NORDSON CORP against the 5 most active filers in the same SIC group.

Dividends

$3.24/share trailing 12 months · +38.5% YoY

Ex-date	Per share
Mar 19, 2026	$0.8200
Dec 17, 2025	$0.8200
Sep 11, 2025	$0.8200
Jun 18, 2025	$0.7800
Mar 20, 2025	$0.7800
Jan 2, 2025	$0.7800
Aug 27, 2024	$0.7800
May 20, 2024	$0.6800
Feb 16, 2024	$0.6800
Dec 18, 2023	$0.6800
Aug 21, 2023	$0.6800
May 22, 2023	$0.6500
Feb 17, 2023	$0.6500
Dec 19, 2022	$0.6500
Aug 22, 2022	$0.6500
May 23, 2022	$0.5100
Feb 18, 2022	$0.5100
Dec 20, 2021	$0.5100
Aug 23, 2021	$0.5100
May 24, 2021	$0.3900
Feb 22, 2021	$0.3900
Dec 17, 2020	$0.3900
Aug 24, 2020	$0.3900
May 22, 2020	$0.3800

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.